G. Paolo M. Rizzardi, MD

Co-Founder &
Managing Partner

–   15+ years in biotechnology industry (2+ years as General Manager)

-Pivotal in the 1st Italian spinoff (MolMed SpA) from bench to IPO, and to market approval of first ATMPs in ex vivo cell&gene therapy for rare diseases and oncology

-Managed drug discovery, R&D, CMC, clinical development, engineering and IP from target validation to market approval

-Managed interactions with regulators (EMA, FDA, AIFA)

-Managed project, set-up and authorisation for market of large GMP facilities for cell&gene therapy products

-Managed significant expansion of business in cell&gene therapy services along with high-value negotiations with academia and pharma and biotech industry

-Managed scouting & evaluation of projects for in-licensing

–  10+ years clinical and R&D experience in academia in Switzerland, UK and Italy, in Internal Medicine and Infectious Diseases divisions

-Clinical activity in major university hospitals in Switzerland and Italy

-Clinical trials design and coordination for HAART and innovative immune-based/vaccination strategies in patients with HIV/AIDS

-80+ peer-reviewed publications

-4000+ citations

h-index 31